Abstract
Musculoskeletal manifestations associated with myelomeningocele (MMC) are common; often resulting in significant functional impairments relating to gait abnormalities, seating imbalance, and skin ulceration. Hip deformities, including soft tissue contractures and dislocation, are seen across neurosegmental levels; the former of which may cause impairments in ambulatory capacity. Hip dislocation in MMC was treated aggressively in the past due to a then commonly held view that reducing these hips would lead to better outcomes. Over the last 20 years, this view has been challenged, with best evidence suggesting that the risks of treatment for hip dislocation in spina bifida far outweigh the benefits. Muscle lengthening, however, can lead to improvements in gait and function. This chapter will review the evidence relating to the treatment of the hip in spina bifida, emphasizing a measured approach when addressing associated deformities, particularly with respect to dislocation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Broughton NS, Menelaus MB, Cole WG, Shurtleff DB. The natural history of hip deformity in myelomeningocele. J Bone Joint Surg Br. 1993;75(5):760–3.
Wright JG. Hip and spine surgery is of questionable value in spina bifida: an evidence-based review. Clin Orthop Relat Res. 2011;469(5):1258–64. https://doi.org/10.1007/s11999-010-1595-y.
Tulpius N. Observationes medicae. Amsterdam: Elzevirium; 1641.
Asher M, Olson J. Factors affecting the ambulatory status of patients with spina bifida cystica. J Bone Joint Surg Am. 1983;65(3):350–6.
Sharrard WJ. The segmental innervation of the lower limb muscles in man. Ann R Coll Surg Engl. 1964;35:106–22.
Duckworth T, Yamashita T, Franks CI, Brown BH. Somatosensory evoked cortical responses in children with spina bifida. Dev Med Child Neurol. 1976;18(1):19–24.
Stark Gordon D, Baker Geoffrey CW. The neurological involvement of the lower limbs in myelomeningocele. Dev Med Child Neurol. 1967;9(6):732–44. https://doi.org/10.1111/j.1469-8749.1967.tb02355.x.
Shurtleff DB. International Myelodysplasia Study Group Database Coordination. Seattle, WA: Department of Pediatrics, University of Washington; 1993.
Charney EB, Melchionni JB, Smith DR. Community ambulation by children with myelomeningocele and high-level paralysis. J Pediatr Orthop. 1991;11(5):579–82.
Mazur JM, Kyle S. Efficacy of bracing the lower limbs and ambulation training in children with myelomeningocele. Dev Med Child Neurol. 2004;46(5):352–6.
Stillwell A, Menelaus MB. Walking ability in mature patients with spina bifida. J Pediatr Orthop. 1983;3(2):184–90.
Swank M, Dias L. Myelomeningocele: a review of the orthopaedic aspects of 206 patients treated from birth with no selection criteria. Dev Med Child Neurol. 1992;34(12):1047–52.
De Souza LJ, Carroll N. Ambulation of the braced myelomeningocele patient. J Bone Joint Surg Am. 1976;58(8):1112–8.
McDonald CM, Jaffe KM, Mosca VS, Shurtleff DB. Ambulatory outcome of children with myelomeningocele: effect of lower-extremity muscle strength. Dev Med Child Neurol. 1991;33(6):482–90.
Samuelsson L, Skoog M. Ambulation in patients with myelomeningocele: a multivariate statistical analysis. J Pediatr Orthop. 1988;8(5):569–75.
Swank M, Dias LS. Walking ability in spina bifida patients: a model for predicting future ambulatory status based on sitting balance and motor level. J Pediatr Orthop. 1994;14(6):715–8.
Selber P, Dias L. Sacral-level myelomeningocele: long-term outcome in adults. J Pediatr Orthop. 1998;18(4):423–7.
Brinker MR, Rosenfeld SR, Feiwell E, Granger SP, Mitchell DC, Rice JC. Myelomeningocele at the sacral level. Long-term outcomes in adults. J Bone Joint Surg Am. 1994;76(9):1293–300.
Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet. 1982;34(6):980–7.
Seller MJ. Recurrence risks for neural tube defects in a genetic counseling clinic population. J Med Genet. 1981;18(4):245–8.
Toriello HV, Higgins JV. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study. Am J Med Genet. 1983;15(4):601–6. https://doi.org/10.1002/ajmg.1320150409.
Yang Y, Chen J, Wang B, Ding C, Liu H. Association between MTHFR C677T polymorphism and neural tube defect risks: a comprehensive evaluation in three groups of NTD patients, mothers, and fathers. Birth Defects Res A Clin Mol Teratol. 2015;103(6):488–500. https://doi.org/10.1002/bdra.23361.
Benedum CM, Yazdy MM, Mitchell AA, Werler MM. Impact of periconceptional use of nitrosatable drugs on the risk of neural tube defects. Am J Epidemiol. 2015;182(8):675–84. https://doi.org/10.1093/aje/kwv126.
Loeken MR. Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C Semin Med Genet. 2005;135C(1):77–87. https://doi.org/10.1002/ajmg.c.30056.
Makelarski JA, Romitti PA, Rocheleau CM, Burns TL, Stewart PA, Waters MA, et al. Maternal periconceptional occupational pesticide exposure and neural tube defects. Birth Defects Res A Clin Mol Teratol. 2014;100(11):877–86. https://doi.org/10.1002/bdra.23293.
Reefhuis J, Honein MA, Schieve LA, Rasmussen SA, National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod. 2011;26(2):451–7. https://doi.org/10.1093/humrep/deq313.
Dreier JW, Andersen AM, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014;133(3):e674–88. https://doi.org/10.1542/peds.2013-3205.
Hibbard E, Smithells RW. Folic acid metabolism and human embryopathy. Lancet. 1965;285(7398):1254. https://doi.org/10.1016/S0140-6736(65)91895-7.
Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51(12):944–50.
Wald NJ, Hackshaw AD, Stone R, Sourial NA. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol. 1996;103(4):319–24.
Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343(22):1608–14. https://doi.org/10.1056/NEJM200011303432204.
Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed). 1981;282(6275):1509–11.
MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131–7.
Centers for Disease Control Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate--United States, 1995–1996 and 1999–2000. MMWR Morb Mortal Wkly Rep. 2004;53(17):362–5.
Shurtleff DB, Menelaus MB, Staheli LT, Chew DE, Lamers JY, Stillwell A, et al. Natural history of flexion deformity of the hip in myelodysplasia. J Pediatr Orthop. 1986;6(6):666–73.
Breed AL, Healy PM. The midlumbar myelomeningocele hip: mechanism of dislocation and treatment. J Pediatr Orthop. 1982;2(1):15–24.
Lindseth RE, Dias LS, Drennan JC. Myelomeningocele. Instr Course Lect. 1991;40:271–91.
Menelaus MB, Broughton NS. The orthopaedic management of spina bifida cystica, Current problems in orthopaedics. 3rd ed. Edinburgh: WB Saunders; 1998.
Buckley SL, Sponseller PD, Magid D. The acetabulum in congenital and neuromuscular hip instability. J Pediatr Orthop. 1991;11(4):498–501.
Gugenheim JJ, Gerson LP, Sadler C, Tullos HS. Pathologic morphology of the acetabulum in paralytic and congenital hip instability. J Pediatr Orthop. 1982;2(4):397–400.
Blundell Jones G. Paralytic dislocation of the hip. J Bone Joint Surg. 1954;36(3):375–84.
Somerville EW. Paralytic dislocation of the hip. J Bone Joint Surg Br. 1959;41-B(2):279–88.
Brookes M, Wardle E. Muscle action and the shape of the femur. J Bone Joint Surg Br. 1962;44-B(2):398–411.
Dias LS, Locher FG, Mazur JM, Olysav D. Femoral neck abnormalities in spina bifida. Clin Orthop Relat Res. 1984;(184):164–8.
Dias LS, Hill JA. Evaluation of treatment of hip subluxation in myelomeningocele by intertrochanteric varus derotation femoral osteotomy. Orthop Clin North Am. 1980;11(1):31–7.
Feiwell E, Sakai D, Blatt T. The effect of hip reduction on function in patients with myelomeningocele. Potential gains and hazards of surgical treatment. J Bone Joint Surg Am. 1978;60(2):169–73.
Keggi J, Banta J, Walton C. The myelodysplastic hip and scoliosis. Eur J Pediatr Surg. 1991;1(Suppl 1):47.
Fraser RK, Bourke HM, Broughton NS, Menelaus MB. Unilateral dislocation of the hip in spina bifida. A long-term follow-up. J Bone Joint Surg Br. 1995;77(4):615–9.
Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol. 1971;13(3):279–303.
Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005;41(4):186–91. https://doi.org/10.1159/000086559.
Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010;52(8):749–53. https://doi.org/10.1111/j.1469-8749.2009.03543.x.
Wong LY, Paulozzi LJ. Survival of infants with spina bifida: a population study, 1979–94. Paediatr Perinat Epidemiol. 2001;15(4):374–8.
McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg. 2000;10(S1):31–2. https://doi.org/10.1055/s-2008-1072411.
Murray CB, Holmbeck GN, Ros AM, Flores DM, Mir SA, Varni JW. A longitudinal examination of health-related quality of life in children and adolescents with spina bifida. J Pediatr Psychol. 2015;40(4):419–30. https://doi.org/10.1093/jpepsy/jsu098.
Rocque BG, Bishop ER, Scogin MA, Hopson BD, Arynchyna AA, Boddiford CJ, et al. Assessing health-related quality of life in children with spina bifida. J Neurosurg Pediatr. 2015;15(2):144–9. https://doi.org/10.3171/2014.10.peds1441.
Rofail D, Maguire L, Kissner M, Colligs A, Abetz-Webb L. Health-related quality of life is compromised in individuals with spina bifida: results from qualitative and quantitative studies. Eur J Obstet Gynecol Reprod Biol. 2014;181:214–22. https://doi.org/10.1016/j.ejogrb.2014.07.048.
Bellin MH, Zabel TA, Dicianno BE, Levey E, Garver K, Linroth R, et al. Correlates of depressive and anxiety symptoms in young adults with spina bifida. J Pediatr Psychol. 2010;35(7):778–89. https://doi.org/10.1093/jpepsy/jsp094.
Arnett J, Lynn Tanner J, Gibbons J, Ashdown BK. Emerging adults in America: coming of age in the 21st century. Washington, DC: American Psychological Association; 2006.
Roach JW, Short BF, Saltzman HM. Adult consequences of spina bifida: a cohort study. Clin Orthop Relat Res. 2011;469(5):1246–52. https://doi.org/10.1007/s11999-010-1594-z.
Hoffman HJ, Hendrick EB, Humphreys RP. The tethered spinal cord: its protean manifestations, diagnosis and surgical correction. Childs Brain. 1976;2(3):145–55.
Mazur JM, Shurtleff D, Menelaus M, Colliver J. Orthopaedic management of high-level spina bifida. Early walking compared with early use of a wheelchair. J Bone Joint Surg Am. 1989;71(1):56–61.
Wallace SJ. The effect of upper-limb function on mobility of children with myelomeningocele. Dev Med Child Neurol Suppl. 1973;(Suppl 29):84–91.
Danielsson AJ, Bartonek A, Levey E, McHale K, Sponseller P, Saraste H. Associations between orthopaedic findings, ambulation and health-related quality of life in children with myelomeningocele. J Child Orthop. 2008;2(1):45–54. https://doi.org/10.1007/s11832-007-0069-6.
Hoffer MM, Feiwell E, Perry R, Perry J, Bonnett C. Functional ambulation in patients with myelomeningocele. J Bone Joint Surg Am. 1973;55(1):137–48.
Huff CW, Ramsey PL. Myelodysplasia. The influence of the quadriceps and hip abductor muscles on ambulatory function and stability of the hip. J Bone Joint Surg Am. 1978;60(4):432–43.
Schoenmakers MA, Uiterwaal CS, Gulmans VA, Gooskens RH, Helders PJ. Determinants of functional independence and quality of life in children with spina bifida. Clin Rehabil. 2005;19(6):677–85. https://doi.org/10.1191/0269215505cr865oa.
Bartonek A, Saraste H. Factors influencing ambulation in myelomeningocele: a cross-sectional study. Dev Med Child Neurol. 2001;43(4):253–60.
Schopler SA, Menelaus MB. Significance of the strength of the quadriceps muscles in children with myelomeningocele. J Pediatr Orthop. 1987;7(5):507–12.
Seitzberg A, Lind M, Biering-Sorensen F. Ambulation in adults with myelomeningocele. Is it possible to predict the level of ambulation in early life? Childs Nerv Syst. 2008;24(2):231–7. https://doi.org/10.1007/s00381-007-0450-2.
Gabrieli AP, Vankoski SJ, Dias LS, Milani C, Lourenco A, Filho JL, et al. Gait analysis in low lumbar myelomeningocele patients with unilateral hip dislocation or subluxation. J Pediatr Orthop. 2003;23(3):330–4.
Alman BA, et al. Function of dislocated hips in children with lower level spina bifida. J Bone Joint Surg Br. 1996;78(2):294–8.
Swaroop VT, Dias L. Orthopedic management of spina bifida. Part I: hip, knee, and rotational deformities. J Child Orthop. 2009;3(6):441–9. https://doi.org/10.1007/s11832-009-0214-5.
Beuriat PA, Szathmari A, Hameury F, Poirot I, Massoud M, Massardier J et al. [Changes in the epidemiology of Spina Bifida in France in the last 30 years]. Neurochirurgie. 2017;63(2):109–111. doi:https://doi.org/10.1016/j.neuchi.2017.01.003.
Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015;351:h5949. https://doi.org/10.1136/bmj.h5949.
North T, Cheong A, Steinbok P, Radic JA. Trends in incidence and long-term outcomes of myelomeningocele in British Columbia. Childs Nerv Syst. 2018;34(4):717–24. https://doi.org/10.1007/s00381-017-3685-6.
Orioli IM, Lima do Nascimento R, Lopez-Camelo JS, Castilla EE. Effects of folic acid fortification on spina bifida prevalence in Brazil. Birth Defects Res A Clin Mol Teratol. 2011;91(9):831–5. https://doi.org/10.1002/bdra.20830.
Canfield MA, Marengo L, Ramadhani TA, Suarez L, Brender JD, Scheuerle A. The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol. 2009;23(1):41–50. https://doi.org/10.1111/j.1365-3016.2008.00975.x.
Centers for Disease Control Prevention (CDC). Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995–2005. MMWR Morb Mortal Wkly Rep. 2009;57(53):1409–13.
Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, Speer MC, et al. Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2008;82(10):662–9. https://doi.org/10.1002/bdra.20511.
Matson MA, Mahone EM, Zabel TA. Serial neuropsychological assessment and evidence of shunt malfunction in spina bifida: a longitudinal case study. Child Neuropsychol. 2005;11(4):315–32. https://doi.org/10.1080/09297040490916910.
McLone DG, Czyzewski D, Raimondi AJ, Sommers RC. Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocele. Pediatrics. 1982;70(3):338.
de Jong TP, Chrzan R, Klijn AJ, Dik P. Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008;23(6):889–96. https://doi.org/10.1007/s00467-008-0780-7.
Muller T, Arbeiter K, Aufricht C. Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol. 2002;12(6):479–84. https://doi.org/10.1097/01.mou.0000039446.39928.32.
Smith K, Neville-Jan A, Freeman KA, Adams E, Mizokawa S, Dudgeon BJ, et al. The effectiveness of bowel and bladder interventions in children with spina bifida. Dev Med Child Neurol. 2016;58(9):979–88. https://doi.org/10.1111/dmcn.13095.
Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM, et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr. 2015;166(2):444–50.e1. https://doi.org/10.1016/j.jpeds.2014.09.039.
Ottolini K, Harris AB, Amling JK, Kennelly AM, Phillips LA, Tosi LL. Wound care challenges in children and adults with spina bifida: an open-cohort study. J Pediatr Rehabil Med. 2013;6(1):1–10. https://doi.org/10.3233/PRM-130231.
Alliaume A. [Fractures of the long bones in myelomeningocele]. Arch Fr Pediatr. 1950;7(3):294–5.
Lock TR, Aronson DD. Fractures in patients who have myelomeningocele. J Bone Joint Surg Am. 1989;71(8):1153–7.
Gabriel K. Natural history of hip deformity in spina bifida. In: Sarwark JF, Lubicky JP, Shriners Hospitals for Children, editors. Caring for the child with spina bifida: Shriners Hospitals for Children, Symposium, Oak Brook, Illinois, April 14–16, 2000. 1st ed. Rosemont, IL: American Academy of Orthopaedic Surgeon; 2001. p. 89.
Carroll NC, Sharrard WJ. Long-term follow-up of posterior iliopsoas transplantation for paralytic dislocation of the hip. J Bone Joint Surg Am. 1972;54(3):551–60.
Samuelsson L, Eklof O. Hip instability in myelomeningocele. 158 patients followed for 15 years. Acta Orthop Scand. 1990;61(1):3–6.
Barden GA, Meyer LC, Stelling FH III. Myelodysplastics--fate of those followed for twenty years or more. J Bone Joint Surg Am. 1975;57(5):643–7.
Park TS, Cail WS, Maggio WM, Mitchell DC. Progressive spasticity and scoliosis in children with myelomeningocele. Radiological investigation and surgical treatment. J Neurosurg. 1985;62(3):367–75. https://doi.org/10.3171/jns.1985.62.3.0367.
Sarwark JF, Weber DT, Gabrieli AP, McLone DG, Dias L. Tethered cord syndrome in low motor level children with myelomeningocele. Pediatr Neurosurg. 1996;25(6):295–301. https://doi.org/10.1159/000121143.
Menelaus MB. Dislocation and deformity of the hip in children with spina bifida cystica. J Bone Joint Surg Br. 1969;51(2):238–51.
Sharrard WJ. Paralytic deformity in the lower limb. J Bone Joint Surg Br. 1967;49(4):731–47.
Vankoski SJ, Sarwark JF, Moore C, Dias L. Characteristic pelvic, hip, and knee kinematic patterns in children with lumbosacral myelomeningocele. Gait Posture. 1995;3(1):51–7. https://doi.org/10.1016/0966-6362(95)90809-7.
Sarwark JF, Lubicky JP, Shriners Hospitals for Children. Caring for the child with spina bifida: Shriners Hospitals for Children, Symposium, Oak Brook, Illinois, April 14–16, 2000. 1st ed. Rosemont, IL: American Academy of Orthopaedic Surgeon; 2001.
Duffy CM, Hill AE, Cosgrove AP, Corry IS, Mollan RA, Graham HK. Three-dimensional gait analysis in spina bifida. J Pediatr Orthop. 1996;16(6):786–91.
Drummond DS, Moreau M, Cruess RL. Post-operative neuropathic fractures in patients with myelomeningocele. Dev Med Child Neurol. 1981;23(2):147–50.
James CC. Fractures of the lower limbs in spina bifida cystica: a survey of 44 fractures in 122 children. Dev Med Child Neurol Suppl. 1970;22(Suppl 22):88+.
Kumar SJ, Cowell HR, Townsend P. Physeal, metaphyseal, and diaphyseal injuries of the lower extremities in children with myelomeningocele. J Pediatr Orthop. 1984;4(1):25–7.
Boytim MJ, Davidson RS, Charney E, Melchionni JB. Neonatal fractures in myelomeningocele patients. J Pediatr Orthop. 1991;11(1):28–30.
Martinelli V, Dell’Atti C, Ausili E, Federici E, Magarelli N, Leone A, et al. Risk of fracture prevention in spina bifida patients: correlation between bone mineral density, vitamin D, and electrolyte values. Childs Nerv Syst. 2015;31(8):1361–5. https://doi.org/10.1007/s00381-015-2726-2.
Szalay EA, Cheema A. Children with spina bifida are at risk for low bone density. Clin Orthop Relat Res. 2011;469(5):1253–7. https://doi.org/10.1007/s11999-010-1634-8.
Valtonen KM, Goksor LA, Jonsson O, Mellstrom D, Alaranta HT, Viikari-Juntura ER. Osteoporosis in adults with meningomyelocele: an unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil. 2006;87(3):376–82. https://doi.org/10.1016/j.apmr.2005.11.004.
Kaufman BA, Terbrock A, Winters N, Ito J, Klosterman A, Park TS. Disbanding a multidisciplinary clinic: effects on the health care of myelomeningocele patients. Pediatr Neurosurg. 1994;21(1):36–44. https://doi.org/10.1159/000120812.
Broughton NS. The hip. In: Broughton NS, Menelaus MB, editors. Menelaus’ orthopaedic management of spina bifida cystica. 3rd ed. London: W.B. Saunders; 1998. p. 135–44.
Morakis E, Wright J. Evidence-based treatment of spina bifida. In: Alshryda S, Huntley J, Banaszkiewicz PA, editors. Evidence-based paediatric orthopaedics: the best answers to clinical questions. 1st ed. New York, NY: Springer; 2016.
Frawley PA, Broughton NS, Menelaus MB. Anterior release for fixed flexion deformity of the hip in spina bifida. J Bone Joint Surg Br. 1996;78(2):299–302.
Mazur JM. Orthopedic complications of myelomeningocele. In: Epps CH, Bowen JR, editors. Complications in pediatric orthopaedic surgery. Philadelphia, PA: Lippincott; 1995. p. 545–64.
Buisson JS, Hamblen DL. Electromyographic assessment of the transplanted ilio-psoas muscle in spina bifida cystica. Dev Med Child Neurol Suppl. 1972;27:29–33.
Rothe MJ. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiological features, risk factors, and latex hypersensitivity. Dermatitis. 1995;6(3):53–61.
Meeropol E, Frost J, Pugh L, Roberts J, Ogden JA. Latex allergy in children with myelodysplasia: a survey of Shriners hospitals. J Pediatr Orthop. 1993;13(1):1–4.
Pearson Michele L, Cole Jeane S, Jarvis William R. How common is latex allergy? A survey of children with myelodysplasia. Dev Med Child Neurol. 1994;36(1):64–9. https://doi.org/10.1111/j.1469-8749.1994.tb11767.x.
Tosi LL, Slater JE, Shaer C, Mostello LA. Latex allergy in spina bifida patients: prevalence and surgical implications. J Pediatr Orthop. 1993;13(6):709–12.
Nieto A, Estornell F, Mazón A, Reig C, Nieto A, García-Ibarra F. Allergy to latex in spina bifida: a multivariate study of associated factors in 100 consecutive patients. J Allergy Clin Immunol. 1996;98(3):501–7. https://doi.org/10.1016/S0091-6749(96)70082-9.
Yassin MS, Sanyurah S, Lierl MB, Fischer TJ, Oppenheimer S, Cross J, et al. Evaluation of latex allergy in patients with meningomyelocele. Ann Allergy. 1992;69(3):207–11.
Slater JE. Latex allergy. J Allergy Clin Immunol. 1994;94(2):139–49. https://doi.org/10.1053/ai.1994.v94.a55437.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Morakis, E., Howard, J.J., Wright, J. (2019). The Hip in Myelomeningocele. In: Alshryda, S., Howard, J., Huntley, J., Schoenecker, J. (eds) The Pediatric and Adolescent Hip. Springer, Cham. https://doi.org/10.1007/978-3-030-12003-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-12003-0_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12002-3
Online ISBN: 978-3-030-12003-0
eBook Packages: MedicineMedicine (R0)